(0.10%) 5 186.08 points
(0.06%) 38 877 points
(-0.08%) 16 337 points
(0.03%) $78.50
(0.64%) $2.21
(-0.36%) $2 322.90
(-0.57%) $27.46
(2.35%) $987.60
(0.19%) $0.930
(0.83%) $10.91
(0.45%) $0.800
(-0.05%) $91.30
Live Chart Being Loaded With Signals
Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein...
Stats | |
---|---|
今日成交量 | 6.01M |
平均成交量 | 2.09M |
市值 | 1.72B |
EPS | HKD0 ( 2024-03-27 ) |
下一个收益日期 | ( HKD0 ) 2024-06-07 |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -4.34 |
ATR14 | HKD0.0100 (0.46%) |
音量 相关性
Jacobio Pharmaceuticals 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Jacobio Pharmaceuticals 相关性 - 货币/商品
Jacobio Pharmaceuticals 财务报表
Annual | 2023 |
营收: | HKD63.52M |
毛利润: | HKD3.20M (5.04 %) |
EPS: | HKD-0.460 |
FY | 2023 |
营收: | HKD63.52M |
毛利润: | HKD3.20M (5.04 %) |
EPS: | HKD-0.460 |
FY | 2022 |
营收: | HKD95.75M |
毛利润: | HKD12.63M (13.20 %) |
EPS: | HKD-0.500 |
FY | 2021 |
营收: | HKD152.81M |
毛利润: | HKD12.83M (8.40 %) |
EPS: | HKD-0.396 |
Financial Reports:
No articles found.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It is also develops JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-1 resistant cancer; JAB-6343, an inhibitor that targets fibroblast growth factor receptor 4 for advanced hepatocellular carcinoma with FGF19 overexpression; JAB-2485, an aurora A kinase inhibitor for solid tumors; JAB-24114, a tumor metabolic pathway for the treatment of solid tumors; and JAB-BX300, a molecule antibody targeting RAS pathway to treat pancreatic and other solid tumors with KRAS mutations. The company has a strategic collaboration with AbbVie Ireland Unlimited Company to develop and commercialize SHP2 inhibitors. Jacobio Pharmaceuticals Co., Ltd. was incorporated in 2015 and is headquartered in Beijing, China.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。